OneMedNet Corporation has filed a Form 8-K announcing that it will implement a 1-for-10 reverse stock split of its common stock. The split was approved by stockholders at the Annual Meeting of Stockholders held on September 18, 2026, and is scheduled to become effective at 12:01 a.m. Eastern Time on September 29, 2026.
The company stated that the reverse split is intended to bring it into compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. As of the filing date, the company noted that the split would reduce the number of outstanding shares from approximately 59,286,450 shares as of September 24, 2026, to about 5,928,645 shares.
Under the terms of the amendment to the company’s Third Amended and Restated Certificate of Incorporation, every ten shares of issued and outstanding common stock will be automatically combined into one share. No fractional shares will be issued; any resulting fractional shares will be rounded up to the nearest whole share. The par value per share and the total authorized number of shares will remain unchanged. The reverse split will proportionately adjust the number of shares available under equity incentive plans and the exercise price and number of shares underlying outstanding warrants and convertible securities.
Following the split, the company’s common stock is expected to continue trading on the Nasdaq Capital Market under the symbol “ONMD.” The new CUSIP number for the stock following the split is 68270C 202. Continental Stock Transfer & Trust Company is serving as the exchange agent and transfer agent for the transaction.
